Status:
COMPLETED
Safety of the Colonoscope Magnetic Imaging Device (ScopeGuide®) in Patients With Implantable Cardiac Devices
Lead Sponsor:
Cambridge University Hospitals NHS Foundation Trust
Conditions:
Cardiac Arrhythmia
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The Olympus ScopeGuide® is a useful tool in speeding up colonoscopy and making it less painful for patients. It is currently contraindicated by the manufacturer for use with patients with implantable ...
Detailed Description
BACKGROUND AND RATIONALE Colonoscopy is the 'gold-standard' diagnostic procedure for visualising the inside of the large bowel. It involves the insertion of a flexible instrument called a "colonoscop...
Eligibility Criteria
Inclusion
- Participant is willing and able to give informed consent for participation in the study.
- Male or Female, aged 18 years or above.
- Must have a permanent pacemaker or implantable cardioverter defibrillator
- Is attending for a routine pacemaker check during the study period
Exclusion
- The participant may not enter the study if ANY of the following apply:
- Cardio-respiratory compromise on the day of the experiment (we propose NYHA Grade 3 or higher as criteria for this)
- Vulnerable adults
Key Trial Info
Start Date :
August 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01825525
Start Date
August 1 2012
End Date
April 1 2013
Last Update
April 9 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Addenbrooke's Hospital
Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ